Smith & Nephew plc SN.

LON: SN. | ISIN: GB0009223206   24/03/2023
1.133,00 GBX (-1,65%)
(-1,65%)   24/03/2023
Grafiek Smith & Nephew plc Grafiek Smith & Nephew plc
donderdag 30 maart 2023
Ex-dividend: 0,23 USD per aandeel. Uitbetaling op 17/05/2023.

Smith & Nephew plc in het nieuws

23 maart 2023 · New evidence demonstrates Smith+Nephew's COBLATION™ Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques · Persbericht

8 maart 2023 · Smith+Nephew to highlight procedural innovations in Sports Medicine during AAOS 2023 Annual Meeting · Persbericht

7 maart 2023 · Smith+Nephew unveils 'Precision in Motion' for its Orthopaedics Arthroplasty portfolio at AAOS 2023 Annual Meeting · Persbericht

7 maart 2023 · Smith+Nephew Sports Medicine advances procedural innovation by launching the QUADTRAC™ Quadriceps Tendon Harvest Guide System and expanded family of ULTRABUTTON™ Adjustable Fixation Devices for ACL reconstruction · Persbericht

6 maart 2023 · Smith+Nephew's VISIONAIRE™ Patient-Specific Instrumentation shown to improve outcome measures for total knee arthroplasty compared with conventional instrumentation · Persbericht

30 januari 2023 · Smith+Nephew receives Innovative Technology designation from Vizient for LEAF™ Patient Monitoring System · Persbericht

1 november 2022 · Smith+Nephew expands procedural innovation with introduction of JOURNEY™ II ROX™ Total Knee Solution · Persbericht

26 september 2022 · Smith+Nephew first to market with revision knee indication on robotics platform · Persbericht

21 september 2022 · Smith+Nephew Academy expands global access to professional medical education through virtual reality and other advanced simulation technologies · Persbericht

14 september 2022 · New randomized controlled trial shows that addition of Smith+Nephew's REGENETEN™ Bioinductive Implant delivers 86% reduction in rotator cuff re-tear rates at 12 months · Persbericht

336x280

Profiel Smith & Nephew plc

Gezondheidstechnologie
Medische Specialiteiten
Productie
Productie van chirurgische apparatuur

CEO: Roland Diggelmann

Werknemers: 18.581

Aandelen Smith & Nephew plc

Beurswaarde: 10,06 miljard GBP

Effecten: 873,36 miljoen

Mijn selecties